As investors look beyond mega-cap tech for the next leg of growth, pharma is quietly moving back into focus — and no two names capture that shift better than Eli Lilly And Co (NYSE: LLY) and Novo No
Abivax surged 1,470% YTD, driven by Obefazimod's clinical progress and takeover speculation, but I rate it Hold due to valuation risk. Obefazimod, a first-in-class oral therapy for ulcerative colitis,
Novo said it expects to launch the weight-loss pill in the U.S. in early January.
Charles Schwab Trust Co increased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 151.4% in the undefined quarter, according to the company in its most recent disclosure with the Securitie
Foster Victor Wealth Advisors LLC lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 79.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities an
Clarius Group LLC cut its stake in Eli Lilly and Company (NYSE: LLY) by 37.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
KMG Fiduciary Partners LLC boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 5.5% during the third quarter, according to its most recent disclosure with the Securities and Exchang
Independence Bank of Kentucky raised its holdings in Eli Lilly and Company (NYSE: LLY) by 40.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 14,521 sh
Signal Advisors Wealth LLC boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 32.9% during the undefined quarter, according to the company in its most recent disclosure with the SE
Trust Point Inc. reduced its position in shares of Eli Lilly and Company (NYSE: LLY) by 23.5% during the undefined quarter, according to the company in its most recent filing with the Securities and E
Red Door Wealth Management LLC grew its position in shares of Eli Lilly and Company (NYSE: LLY) by 35.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities
Clarity Financial LLC increased its holdings in Eli Lilly and Company (NYSE: LLY) by 2.6% in the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 3
Perpetual Ltd raised its stake in shares of Eli Lilly and Company (NYSE: LLY) by 82.4% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 2,736 shares of th
BDF Gestion decreased its holdings in Eli Lilly and Company (NYSE: LLY) by 17.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. T
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE